WHY EVERY WOMAN SHOULD CONSIDER ADDING THERMAL IMAGING TO THEIR BREAST HEALTH PROTOCOL

Author: Angie Lacoste CTT, Founder ThermaVUE® Medical Thermal Imaging

Good health is wealth! The key lies in having a proactive approach to protect and safeguard our health.

We know it’s not pleasant or easy to talk about serious health matters like breast cancer but as women we are far more predisposed to this terrible disease. We need to do everything we can to protect ourselves from it by using all procedures and technologies available for the detection of the earliest markers also as an assessment of future risk.

EARLY DETECTION SAVES LIVES!

So Here’s Why Should Every Woman Add Thermal Imaging To Their Breast Health Protocol . .

Breast cancer is the most common cancer in women and every woman is at risk of developing it.

According to NHS and BreastCancerNow.org, 1 in 7 women in UK will be diagnosed with breast cancer in their lifetime, equating to over 55000 women in UK being diagnosed with the disease each year.

The risk increases with age and is also higher in women whose close relatives have had the disease however, did you know that 85% of all breast cancer cases are where there is no family history(1a) ?

Yes, sadly, most people wrongly think they are not at risk because no-one in their family has been diagnosed with breast cancer. Sadly, this isn’t true – everyone is at risk, and the risk increases if there’s family history of the disease.

Women without children, and those who have had their first child after age 30, also seem to be at higher risk(1). Men can also get breast cancer (about 1 in 1000 according to NHS and BreastCAncerNow.org), however women remain pre-disposed to breast cancer due to their lifelong exposure to estrogen and subsequent imbalance of hormones due to menopause. 80% of breast cancers are estrogen receptive(1b). HRT is known to increase a womans’ risk of breast cancer by 66% (1a).

As we all know, early detection is crucial in saving lives. We must use every means possible to detect breast cancers when there is the greatest chance for survival, and this is why you should add ThermaVUE® Medical Thermal Imaging to your breast health protocol.

ThermaVUE® Medical Thermal Imaging is 100% safe and an effective method for breast imaging for the detection of the earliest markers for breast cancer and imbalance of hormones in the breasts.

  • Especially for those aged 20 – 49 or over 70 who are not invited for breast screening (tri-annual mammograms)
  • Between tri-annual mammograms for ladies aged 50 – 70
  • Where mammograms are not suitable:
  • Younger ladies and ladies with dense breast tissue
  • Breast implants
  • Breast reductions
  • After surgery
  • Pacemaker

Thermal Imaging was approved in 1982 by the FDA (Food and Drug Administration) in USA as an adjunctive risk assessment tool for the detection of breast cancer as well as various other vascular diseases and conditions.

At ThermaVUE® Medical Thermal Imaging, our highly sophisticated and sensitive infrared thermal cameras carry the FDA 510k certification for adjunctive diagnostic screening for the detection of breast cancer and other uses such as peripheral vascular disease, neuromusculoskeletal disorders, extra cranial cerebral and facial vascular disease, thyroid gland abnormalities and various other neoplastic, metabolic and inflammatory conditions.

Here’s how it all works . . .

ThermaVUE® uses these highly sophisticated infrared cameras to detect and produce high-resolution images of the temperature variations on the skin due to heat being radiated by the body. The images and changes of these patterns provide an accurate and up to date risk assessment of how the body is functioning based on the physiological heat being produced by increased or decreased vascular activity or metabolic changes associated with inflammation in the body.

In the breasts, this metabolic activity and vascular circulation in both pre-cancerous tissue and the area surrounding a developing breast cancer is almost always higher than in normal breast tissue.

In an ever-increasing need for nutrients, cancerous tumours increase circulation to their cells by holding open existing blood vessels, opening dormant vessels, and creating new ones – a process called neoangiogenesis. This process frequently results in an increase in regional surface temperatures of the breast. Because of the extreme sensitivity of the cameras, the detection of these temperature variations may be among the earliest signs of breast cancer and/or a pre-cancerous state of the breast (3,6,7,8,9).

While mammography, ultrasound, MRI, and other structural imaging tools rely primarily on finding the physical tumour, Thermal Imaging (or infrared) is based on detecting the heat produced by increased blood vessel circulation and metabolic changes associated with a tumour’s genesis and growth. By detecting minute variations in normal blood vessel activity, infrared imaging may find thermal signs suggesting a pre-cancerous state of the breast or the presence an early tumour that is not yet large enough to be detected by physical examination, mammography, or other types of structural imaging (3,6,7,8,9).

Certain types of cancers will not be detected (approximately 20%) by mammography for various reasons(10), but some of these cancers will be discovered by medical thermal imaging (3,6,7,8,9).

These neurochemical signals may be the only sign that a problem exists, a remnant of injury indicating that healing has not finished, or a signal sent in advance of significant damage to the body. With this information in hand, you and your health care provider can outline a method for treating a current problem or possibly preventing future problems before they cause irreversible damage.

Many patients are also confused with regard to their condition. For example, patients with chronic pain who have had treatment with little or no relief may have been treated for the wrong condition. Infrared imaging has helped many patients get to the cause of their condition so that proper treatment can be rendered.

The applications of ThermaVUE® Medical Thermal Imaging are broad and range from simple soft tissue injury to a risk assessment marker for breast cancer.

It is important to note that thermal imaging (also known as infrared imaging, thermography or thermology), like other imaging procedures (e.g. CT, MRI, mammography, ultrasound) does not provide a diagnosis. Only your physician can provide you with a diagnosis.

Thermal imaging cannot be used as a “body scan” to search for metastasis (the spread of cancer) or internal organ pathologies. There are many other tests that can provide true screening (early detection) for these conditions –thermal imaging cannot. Thermal Imaging is not a stand-alone test, but an additional procedure that your doctor can use along with other tests to evaluate your health.

What most of us are accustomed to when we think of medical imaging is the use of X-ray, CT, MRI, or ultrasound. All of these imaging tools are considered structural imaging technologies – they look inside the body for structural changes such as broken bones, tumours, damage to organs, etc. What separates these technologies from infrared imaging is that Thermal Imaging detects infrared (heat) markers that reflect the body’s subtle underlying chemical and nervous system signals. This allows us to look at how the body is functioning.

ThermaVUE® Medical Thermal Imaging is

  • 100% safe
  • Non-invasive, no contact
  • No pain,
  • No compression
  • No radiation
  • Accuracy – no false positives
  • Suitable for everyone of any age
  • Suitable for women with a pacemaker, dense breasts, implants, those who have undergone surgery and those who fall outside of routine mammograms analysis
  • Allows for more frequent imaging to monitor changes and / or healing as a result of treatment and or lifestyle choices (including HRT and removal of Soy and other phytoestrogens from the diet).
  • Quick and simple

However, as noted above, Medical Thermal Imaging is a physiological test, it does not have the ability to pinpoint the location or size of a tumour nor can it detect 100% of all cancers. Consequently, Thermal Imaging’s role is in addition (as an adjunct) to structural imaging like mammography, ultrasound, MRI and physical examination, not in lieu of.

Experts have concluded that no one procedure or method of imaging is solely adequate for breast cancer screening (1,2,6). Studies show there is an increase in survival rate when breast self-exams, physician exams, breast thermography and structural imaging like mammography, ultrasound and MRI are used together in a multi-modal approach providing the earliest detection system available to date (3,7,8,9). If treated in the earliest stages, survival rates greater than 95% are possible (3,6).

This is particularly good news for all women who have concerns about their breast health.

Since it has been determined that 1 in 7 women will get breast cancer, we must use every means possible to detect cancers early when there is the greatest chance for survival.

Simply put, early detection saves lives.

We look forward to being of service to you and your loved ones for the peace of mind or the information to follow up and act on the earliest markers to take action to protect and safeguard your health.

Thank you for taking a pro-active approach to your health and well-being and please share this important life-saving information with those you care about.

Best wishes for good health and happiness.

Angie

Angie Lacoste CTT

Founder & CEO

ThermaVUE® Medical Thermal Imaging

Breast and Body Thermal Imaging

Tel: 0333 772 7749

Email: Scans@ThermaVUE.co.uk

www.ThermaVUE.co.uk

Redefining the ‘EARLY’ in ‘EARLY detection saves lives’!

REFERENCES (some courtesy BreastThermography.org)

1.American Cancer Society – Breast Cancer Guidelines and Statistics, 2009-2010

1a. MacMillan.org

1b.Breast Cancer.org  https://www.breastcancer.org/symptoms/diagnosis/hormone_status/read_results

  1. I. Nyirjesy, M.D. et al; Clinical Evaluation, Mammography and Thermography in the Diagnosis of Breast Carcinoma. Thermology, 1986; 1: 170-173.
  2. M. Gautherie, Ph.D.; Thermobiological Assessment of Benign and Malignant Breast Diseases. Am. J. Obstet. Gynecol., 1983; V 147, No. 8: 861-869.
  3.  C. Gros, M.D., M. Gautherie, Ph.D.; Breast Thermography and Cancer Risk Prediction. Cancer, 1980; V 45, No. 1: 51-56.
  4. P. Haehnel, M.D., M. Gautherie, Ph.D. et al; Long-Term Assessment of Breast Cancer Risk by Thermal Imaging. In: Biomedical Thermology, 1980; 279-301.
  5. P. Gamigami, M.D.; Atlas of Mammography: New Early Signs in Breast Cancer. Blackwell Science, 1996.
  6. J. Keyserlingk, M.D.; Time to Reassess the Value of Infrared Breast Imaging? Oncology News Int., 1997; V 6, No. 9
  7.  P.Ahlgren, M.D., E. Yu, M.D., J. Keyserlingk, M.D.; Is it Time to Reassess the Value of Infrared Breast Imaging? Primary Care & Cancer (NCI), 1998; V 18, No. 2.
  8. N. Belliveau, M.D., J. Keyserlingk, M.D. et al ; Infrared Imaging of the Breast: Initial Reappraisal Using High-Resolution Digital Technology in 100 Successive Cases of Stage I and II Breast Cancer. Breast Journal, 1998; V 4, No. 4
  9. IACT-org.org & Index Medicus – J Thermology, Acta Thermographica, J Breast

2020-02-16T12:55:50+00:00